Anybody else with updates on what we should expect in the coming...

Anybody else with updates on what we should expect in the coming weeks.

My thoughts are, next week we should see appendix 4c 31 Dec 23' qtr & cashflow report. Looking for updates on:
- Stage 2 multi-site clinical trails updates since it had reached recruitment target back in Nov 23'. In the 27/11/23 ASX release it noted "Once all the data is received from the sites and core imaging lab, it will be processed with the Stage 2 results anticipated to be reported in Q1 CY2024".
- FDA submission updates for emu product and other FDA engagements. Other regulatory submissions and approvals.
- Activate Stage 3 trail (pre-validation) to allow recruitment to continue in the interim at the 3 sites. 30 hemorrhagic patients.
- Other grant applications and awards.
- Modern Manufacturing Initiative additional payments.
- Cashflow commentary.
- Australian Stroke Alliance collaboration updates.
- Commercial partnerships & strategic relationships.
- Gen 2 advanced prototype bench testing & healthy volunteer studies, proof of concept unit built and road & air trails.
- Establishment of commercial manufacturing.

Below was from the AGM CEO presentation 15/11/23.